UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
Streetinsider.com's Hot Lunchtime Reads 04/04: (WAG) (AAPL) (FB) (BBRY) (VOD)
-
Cardinal Health (CAH) Needs CVS Renewal After Walgreen Loss - Analyst
-
Notable 52-Week Highs and Lows of the Day 03/13: (WAG) (IPG) (DFS) High; (SPPI) (VELT) (CLF) Low
-
UPDATE: Walgreen (WAG) Ramps on UBS Upgrade; Invest for 'Big Picture'
-
Notable Analyst Rating Changes 03/13: (ORCL) (COH) (WAG) Upgraded; (VELT) (VLO) (CLMS) Downgraded
-
StreetInsider.com Pre-Open Movers 03/13: (DRL) (PPHM) (FIG) Higher; (SPPI) (VELT) (EXPR) Lower (more...)
-
Streetinsider.com's Hot Lunchtime Reads 02/21: (T) (ALGT) (WAG) (KO) (PG)
-
Notable Analyst Rating Changes 09/25: (SWY) (GFI) (TIVO) Upgraded; (PAYX) (LEN) (ADP) Downgraded
-
UPDATE: UBS Downgrades Walgreen (WAG) to Neutral
-
Notable Analyst Rating Changes 07/23: (MDC) (ONXX) (BYD) Upgraded; (MAR) (VRSN) (WAG) Downgraded
-
UBS Reiterates a 'Neutral' on Rite-Aid (RAD); A Few Longer-Term Tailwinds, But Staying Sidelined For Now
-
UBS Maintains a 'Buy' on Cardinal Health (CAH); Color on Safeway Contract
-
UBS Raises Numbers on CVS Caremark (CVS); Comments From Conference Call
-
UBS Maintains a 'Buy' on Walgreen (WAG); Downside Risk Priced In, Creating Favorable Risk/Reward Balance
-
Streetinsider.com's Hot Lunchtime Reads 03/02: (BAC) (RAD) (ZNGA) (MWW) (MYL) (DKS)
-
UBS Maintains a 'Buy' on CVS Caremark (CVS); Raising FY12/13 EPS Estimates
-
UBS Maintains a 'Neutral' on Rite-Aid (RAD); Expect Accelerated EBITDA in Calendar ‘12
-
Morning Movers 02/02: (CEDC) (DSCO) (GMCR) (RLD) Higher; (MERU) (SHOR) (EDMC) (RSTI) Lower
-
UBS Maintains a 'Buy' on Walgreen (WAG); January Comps Will Represent First Month Without ESRX
-
Notable Analyst Rating Changes 01/19: (BSX) (HMA) (UBS) Upgraded; (CVA) (SYK) (DHI) Downgraded
-
UBS Maintains a 'Buy' on Express Scripts (ESRX); Raising Estimates for Medco Merger
-
UBS Maintains a 'Neutral' on CVS Caremark (CVS); Raising ‘13 EPS for Generics/PBM Mojo
-
UBS Maintains a 'Buy' on CVS Caremark (CVS); Post-Call: Plenty of Positive Datapoints
-
UBS Maintains a 'Buy' on Walgreen (WAG); Lowering EPS Estimates; Still Assume ESRX Resolution in Published Estimates
-
Pre-Open Movers 09/06: (TIN) (VRUS) (BTH) Higher; (CS) (DNKN) (BAC) Lower (more...)
-
Notable Analyst Rating Changes 08/23: (JNPR) (NVDA) (JASO) Upgraded; (STP) (WAG) (PEG) Downgraded
-
UPDATE - UBS Initiates Coverage on Walgreen (WAG) with a Buy; Generics + SG&A Leverage = EPS Growth
-
UPDATE - UBS Initiates Coverage on Rite Aid (RAD) with a Neutral; Between A Rock and a Hard Place
-
Notable Analyst Rating Changes 06/01: (BLK) (ESV) (CNP) Upgraded; (NOK) (SQNS) (HNZ) Downgraded
-
UBS Starts Walgreen (WAG) at Buy, Rite Aid (RAD) at Neutral
-
Notable Analyst Rating Changes 05/26: (HST) (FITB) (CTSH) Upgraded; (RSH) (LULU) (CAVM) Downgraded
-
Notable Analyst Rating Changes 03/29: (WAG) (BWC) (MAR) Upgraded; (BP) (ATPG) (PM) Downgraded
-
Daily State of the Markets 01/04: And They're Off!
-
Notable 52-Week Highs and Lows of the Day 12/22: WAG, ARMH, JBL, MAT, NXPI High; CAK Low
-
UPDATE - UBS Upgrades Walgreen (WAG) to Buy; Time to Unleash Higher Profitability?
-
UBS Upgrades Walgreen (WAG) to Buy
-
Notable Analyst Rating Changes 06/22: VRX, LNCR, MAT, ARBA Upgraded; BVF, BIG, WAG, NOV Downgraded
-
Notable Analyst Rating Changes 06/11: SQNM, SVVS, BMY, X Upgraded; LGF, AGU, WAG, THO Downgraded
-
Walgreen (WAG) Shares Sink Following UBS' Mid-Day Downgrade
-
Rite Aid (RAD) Higher On Speculation It Could Be Takeover Bait After Walgreen/Duane Reade Deal
-
Highlights From WAG's Q1 Conference Call: Sales Were $16.4 Billion, Up 9.5% Y-O-Y
-
Walgreen's (WAG) Q110 Earnings Preview: Potential Boost from H1N1 Vaccines?
-
UBS Upgrades Walgreen (WAG) to Buy, Raises Price Target to $46
-
Stocks That Could Rise As Cases Of The Swine Flu Increase (RAD, GENZ, GILD, UTHR, XRAY)
-
Notable Analyst Rating Changes 8/27: GHL, DLTR, WHR, KNX, WAG, FWLT Upgraded; ATRO, JTX, SIGM, TREE Downgraded
-
David Moenning's Daily State of the Markets: 4/9
-
David Moenning's Daily State of the Markets: 01/05
-
David Moenning's Daily State of the Markets: 12/02
-
David Moenning's Daily State of the Markets: 10/03
-
Notable Analyst Rating Changes 9/30: WFC, INTC, SOV Upgraded; WAG, FITB, RRI Downgraded
